Literature DB >> 3985600

Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.

E J Goldstein, D M Citron.   

Abstract

The activity of cefbuperazone against 266 strains of anaerobic bacteria was determined by the agar dilution method and compared with cefoxitin, moxalactam, piperacillin, and clindamycin. All strains were recent clinical isolates from community hospitals. All agents tested showed good activity against Bacteroides fragilis, Fusobacterium spp., Propionibacterium spp., Clostridium septicum, Clostridium perfringens, and the anaerobic, gram-positive cocci and gram-negative cocci. Cefbuperazone, cefoxitin, and moxalactam had poor activity against Bacteroides thetaiotaomicron, Bacteroides ovatus, and Bacteroides distasonis. The susceptibility of other Clostridium spp., Lactobacillus spp., and Eubacterium lentum was variable. Our community hospital isolates showed a difference in susceptibility patterns from those reported from university and research centers. This supports the recommendation that clinical microbiology laboratories, including those in community hospitals, need to perform susceptibility testing on representative clinical isolates.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985600      PMCID: PMC176230          DOI: 10.1128/AAC.27.2.162

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Susceptibility of anaerobes to cefoxitin and other cephalosporins.

Authors:  F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

2.  Abdominal trauma, anaerobes, and antibiotics.

Authors:  H Thadepalli; S L Gorbach; P W Broido; J Norsen; L Nyhus
Journal:  Surg Gynecol Obstet       Date:  1973-08

3.  In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.

Authors:  M Tai; Y Fukuoka; A Yotsuji; K Kumano; M Takahata; H Mikami; T Yasuda; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

4.  Management of anaerobic infections.

Authors:  S M Finegold; J G Bartlett; A W Chow; D J Flora; S L Gorbach; E J Harder; F P Tally
Journal:  Ann Intern Med       Date:  1975-09       Impact factor: 25.391

5.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

6.  Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics.

Authors:  D Kaye; W Kobasa; K Kaye
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

7.  Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

8.  Variability in the susceptibility pattern of Bacteroides fragilis in four Detroit area hospitals.

Authors:  R E Bawdon; E Rozmiej; S Palchaudhuri; J Krakowiak
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

Review 9.  Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species.

Authors:  B D Kirby; W L George; V L Sutter; D M Citron; S M Finegold
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

10.  In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.

Authors:  J E Brown; V E Del Bene; C D Collins
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

View more
  1 in total

Review 1.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.